CAS 141223-71-4
:N-cbz-val-lys-met 7-amido-4-*methylcoumarin
- Z-Val-Lys-Met-AMC
Z-Val-Lys-Met-AMC
CAS:The motif VKM corresponds to APP (669-671). Substrate for Amyloid A4-generating enzymes and cathepsin B. Hook et al. used Z-VKM-MCA to detect β-secretase activity in isolated chromaffin vesicles.Formula:C34H45N5O7SPurity:> 98%Color and Shape:White LyophilisateMolecular weight:667.83L-Methioninamide, N-[(phenylmethoxy)carbonyl]-L-valyl-L-lysyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-
CAS:Formula:C34H45N5O7SMolecular weight:667.8154Z-Val-Lys-Met-MCA
CAS:Z-Val-Lys-Met-MCA is a synthetic peptide that can act as an inhibitor or activator. Z-Val-Lys-Met-MCA binds to the receptor and inhibits the receptor from binding with its ligand, which prevents activation of the receptor. It also has been shown to activate other receptors, such as ion channels, by binding to them. This makes it an important research tool for understanding protein interactions.
Formula:C34H45N5O7SPurity:Min. 95%Molecular weight:667.82 g/molZ-Val-Lys-Met-AMC acetate salt
CAS:Bortezomib is a proteasome inhibitor that binds to the catalytic site of the proteasome and inhibits its activity. Bortezomib is used as an anticancer agent to treat multiple myeloma, T-cell lymphomas, and other cancers. It has been shown to inhibit the growth of cancer cells and slow tumor progression in animal models. The drug has also been shown to decrease insulin resistance in mice with high blood sugar levels by inhibiting histone deacetylase (HDAC). This inhibition leads to increased expression of genes that are involved in glucose metabolism and decreased expression of genes that regulate fat production.
The drug also binds tightly to the insulin receptor, which may lead to improved glucose uptake into cells.Formula:C34H45N5O7SPurity:Min. 95%Molecular weight:667.82 g/mol


